Doximity, Inc. (NYSE: DOCS) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $5.5B. The Maz Rating grades it against the other companies in its sector.
Doximity, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $31.11, Doximity, Inc. trades at 41.6x trailing earnings, 8.4x sales and 6.0x book value, with an EV/EBITDA of 24.2. Over the last twelve months it generated about $659M of revenue and $133M of net income. It runs a gross margin of 86.8%, an operating margin of 26.3% and a net margin of 21.1%. It shows return on equity of 14.8%, return on invested capital of 12.6% and a free cash flow yield of 5.4%. On the balance sheet: a debt-to-equity ratio of 0.01 and a current ratio of 6.37. Over the past 52 weeks the share price ranged from $17.15 to $51.85, with a beta of 1.29.
Doximity, Inc. does not currently pay a dividend.
24 Wall Street analyst ratings cover the stock: 1 Strong Buy, 8 Buy, 13 Hold and 2 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.